Skip to content
GLP-1 Scorecard
Menu

Head-to-head · WeighScore

Next Vial vs Rivas Medical Weight Loss

Next Vial
Graded #345

Higher grade

vs+3.6999999999999957
Rivas Medical Weight Loss
Graded #438

Lower grade

The verdict

Next Vial takes it — 59.3/100 to 55.6/100.

Next Vial grades higher on WeighScore, our editorial score across cost value, dose & formulation, clinical oversight, labs & monitoring, fulfillment and contract terms. Fully online GLP-1 telehealth marketplace connecting patients with licensed providers for compounded semaglutide and tirzepatide injections, including microdose options.

We may earn a commission if you start care through some of these links, at no extra cost to you. It never moves the WeighScore, which is the weighted average of the six factors shown for every provider, and what we write about a provider is the same either way. See our disclosure.

Factor by factor

The same six graded dimensions, side by side. See the methodology.

Cost valueRivas Medical Weight Loss +5
40
45
Dose & formulationNext Vial +12
52
40
Clinical oversightNext Vial +1
82
81
Labs & monitoringRivas Medical Weight Loss +1
52
53
FulfillmentNext Vial +21
86
65
Contract termsEven
55
55
Next Vial · left barRivas Medical Weight Loss · right bar

The numbers

MetricNext VialRivas Medical Weight Loss
WeighScore59.3/10055.6/100
GradeCC
Scorecard rank#345#438
Semaglutide$250/mo (compounded)Not disclosed
TirzepatideNot disclosedNot disclosed
Coverage49 states3 states
Brand-name accessCompounded onlyCompounded only
Oral / sublingualInjection onlyInjection only
Next Vial

Graded #345 · C

Strengths

  • LegitScript verified with named pharmacy partner (Manifest Pharmacy, Greer, SC)
  • No membership fees — one all-in price covering consultation, medication, and shipping
  • Compounded semaglutide, tirzepatide, and microdose options available
  • Free rushed shipping; serves 49 states nationwide
  • Board-certified physician oversight with ongoing provider support

Where it loses points

  • Tirzepatide pricing not listed publicly (starting price covers GLP-1 generally)
  • Compounded medications are not FDA-approved
  • Labs and nutritional coaching not disclosed
  • Microdose pricing not published on product page
  • Alaska not listed among served states

Strengths

  • Physician-founded (Paul Rivas MD) with 15 clinics plus telehealth
  • Flat price for any dose; weekly provider visits included in every payment
  • Offers both compounded semaglutide and tirzepatide

Where it loses points

  • Expensive: about $498/mo for semaglutide and $715/mo for tirzepatide (billed weekly)
  • Only available in Maryland, Virginia, and Florida
  • Weekly-visit concierge model requires more frequent engagement than mail-order

Also worth a look

Neither is our top-graded pick — CoreAge Rx leads the scorecard

Across all 499 providers, CoreAge Rx grades highest at 91.8/100 (A−). Top of the scorecard: flat transparent pricing, both molecules, nationwide — no teaser-rate games.

Pricing/verification reflect each provider's public disclosures at last grading; the WeighScore is our editorial judgment per the methodology. Prices change — confirm on each provider's site. Not medical advice; see our disclosure.

← Back to the scorecard